Disposition kinetics of 7,12-dimethylbenz(a)anthracene in rats.
One of the most potent carcinogens is 7,12-dimethylbenz(a)anthracene (7,12-DMBA), which is used routinely to conduct studies to evaluate carcinogen inhibitors. Its pharmacokinetics have not been reported in the literature. In view of its significant effects on drug metabolizing enzymes and clearance mechanisms, it is important to know its disposition characteristics. In this study, we monitored the disposition characteristics of 7,12-DMBA in rats as a function of dose range commonly used in carcinogenesis studies. A mean residence time of 40-55 min was observed; the total body clearance ranged from 8-13 l kg-1. No effect of dose was observed on the pharmacokinetic parameters. This suggests that the dose-dependent effects of 7,12-DMBA carcinogenesis are related to its transient disposition characteristics.
Niazi
S K
SK
Department of Pharmacodynamics, University of Illinois, Chicago 60612.
Hussain
M
M
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity; D000818:Animals; D002273:Carcinogens / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D007275:Injections, Intravenous; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley
D002273:Carcinogens; D015127:9,10-Dimethyl-1,2-benzanthracene